Skip to search formSkip to main contentSkip to account menu

Osanetant

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
New Ways of Antipsychotic Dosing Considering the few new medications being developed for schizophrenia, it is recognized that… 
2007
2007
Talnetant and osanetant, two structurally diverse antagonists of neurokinin-3 receptor (NK3), displayed distinct modes of action… 
2007
2007
Strategies for the use of germanium-based linkers for the phase-tagged synthesis of isotopically labelled intermediates are… 
Review
2003
Review
2003
This review describes the patent applications and relevant scientific literature published during 2002 in the field of novel… 
Review
2001
Review
2001
Osanetant is a neurokinin (NK3) receptor antagonist under development by Sanofi-Synthélabo (formerly Sanofi) as a potential… 
1999
1999
Crystallization process of osanetant, characterized in that i) osanetant is crystallized containing less than 20% impurities in… 
1997
1997
Aerosolized substance P (0.1 M, for 30 min) induced airway hyperresponsiveness in guinea-pigs 24 h after they were pre-treated…